LDG Laboratories Dr. Gansauge in Berg
World-leading clinic that stands out with its comprehensive approach and exceptional success rates in DC therapy, backed by extensive research and clinical experience.
Cancer is one of the leading causes of death among humanity, with approximately 20 million new cases each year and 9.7 million cancer deaths worldwide [1]. About 1 in 5 people will develop cancer in their lifetime, making it a global health concern. There are different treatment options available, but no one can guarantee a complete cure. Though there is hope, in recent years, 5-year survival has improved dramatically thanks to emerging therapies. Now, 7 in 10 people survive their diagnoses more than five years, compared to 5 in 10 in the 90s [2].
And advances keep developing. In 2011, American immunologist Ralph Steinman received the Nobel Prize for the discovery of dendritic cells, which laid the basis for a new way of immunotherapy [3]. Dendritic cell-based immunotherapy involves the administration of individually manufactured vaccines tailored to a person's tumor genetic characteristics [4]. This therapy is indicated even for patients who have not responded to other therapies.
Booking Health's specialists elaborate comprehensive medical programs and help patients undergo dendritic cells in cancer immunotherapy Germany provides in specialized hospitals with high treatment success rates.
Get a tailored treatment strategy for my caseWhat Are Dendritic Cells, and What Is This Therapy Based On?
Dendritic cells are a special type of immune cell that mediate the immune response towards different agents that are not supposed to grow or replicate in our organism. They originate from bone marrow and circulate throughout the body, in different tissues and vessels, to detect pathogens or malignancies. They capture the foreign or abnormal substances (antigens) – such as viruses, bacteria, or tumor proteins and put the special signaling tools on the membrane. The T-cells read those signals and start the process of recognizing and attacking harmful targets.
Often, tumor microenvironment releases immunosuppressive cytokines that prevent them from developing and growing, and it is called tumor-induced dendritic cell dysfunction [5]. This limits the natural recognition of cancer and disrupts the immune response.
Modern immunocine dendritic cell treatment allows for the DC to develop in laboratory settings. This lets for effective antigen presentation by excluding the tumor microenvironment. There, they are getting a chance to fully develop after being exposed to tumor-specific antigens (proteins from the patient’s own tumor), which activate the specific immune response.
To learn more about dendritic cell based therapeutic cancer vaccines Germany offers, watch the interview with a leading professor in the field of modern immunotherapy and DC – Prof. Gansauge. In his comprehensive talk, he explains how dendritic vaccination can be seamlessly integrated with other treatment methods to improve survival and maintain quality of life.
VIDEO
Prof. Frank Gansauge:
Dendritic Cell Therapy in Cancer Treatment
Dendritic Cell Therapy
BOOK CONSULTATION
Why Is Dendritic Cell Therapy Gaining Increasing Trust Among Cancer Patients?
Cancer treatment with DC is a new, emerging area of oncology in Europe, part of immunotherapy. Specialized oncology centers offer this type of treatment to an increasing number of patients. The most actively visited hospitals for dendritic cells therapy for cancer treatment in Germany are connected with the high level of medical care and the extensive experience of German healthcare professionals.
Over the past decade, this emerging immunotherapy has been actively studied as a monotherapy and in combination with other treatments. The results of the studies were encouraging: they demonstrated better control of the oncological process, a higher chance of achieving remission, and a lower risk of recurrence due to long-term antitumor immunity.
For instance, a recent comprehensive review by Khanmiri et al. (2026) [7] highlights dendritic cell vaccination (DCV) as a promising approach to immunotherapy. The review outlines DCV's unique ability to coordinate both innate and adaptive immune responses against tumors, making it particularly valuable in cases where traditional drugs have limited efficacy. It is indicated that, in patients who underwent combination treatment, the response group exhibited superior five-year overall survival rates compared to the non-response group (53.8% vs. 25%, respectively).
Another research by Michal Kyr et al. (2024) [8] studied patients with relapsed or high-risk solid tumors. These groups often have a poor prognosis and limited treatment options available. After using DCV, often paired with checkpoint inhibitors, disease control was achieved in 53.8% patients. The treated group had about half the risk of death or further progression over 2 years compared to those who did not receive the vaccine. This shows that the treatment provides a long-term immune effect, meaning the immune system continues working against the cancer over time.
Thanks to this, the dendritic cell vaccines (DC vaccines) have been included in the updated protocols for the treatment of many types of tumors, such as melanoma, glioblastoma, osteosarcoma, pleural mesothelioma, colon cancer, breast cancer, kidney cancer, lung cancer, pancreatic cancer, and so on.
Dendritic cells cancer treatment Germany provides offers a promising alternative to traditional cancer treatments, potentially improving prognosis by stimulating the immune system to target the tumor. This innovative approach can address various cancer signs, including bone pain, while potentially enhancing overall healing and reducing long-term costs compared to conventional therapies. The therapy's effectiveness is often assessed through specific markers and its ability to increase immunogenicity, though results may vary depending on individual patient factors and tumor characteristics.
The survival data from recent studies are significant not because they describe an experimental curiosity but because they describe a shift in what is clinically achievable for patients who have already exhausted standard options.
The gap between that clinical reality and what the research now shows is not a failure of medicine. It is a failure of access: DCV requires GMP-compliant laboratory infrastructure, a trained immunology team, and a center that has performed the procedure in sufficient volume to have refined its protocols, none of which exist outside a small number of specialized facilities globally.
For patients navigating this from abroad, Booking Health conducts a case-specific medical review before any recommendation is made — because eligibility for DCV depends on immune cell count, tumor profile, and prior treatment history, and a general inquiry to a clinic is not the same as an expert assessment of whether the method is appropriate for a specific case.
GET A SECOND OPINION FOR MY CASEDendritic Cell Therapy – A New Effective Cancer Treatment
Conventional cancer treatments include minimally invasive surgical manipulations and open surgeries, chemotherapy, and different radiation therapy modalities. Hormone therapy and targeted therapy are also common approaches, working to block cancer growth by interfering with specific molecules or receptors.
Cancer immunotherapy by dendritic cells Germany offers represents a new generation of malignancy treatment. Instead of directly attacking cancer, it strengthens the patient's immune system. This therapy turns a patient’s dendritic cells into specialized cancer-fighting agents that can recognize and target cancer specifically. Unlike conventional treatments, this approach helps the body develop a safer, natural defense against cancer.
A 2024 study by Kamigaki et al. [9] highlights how immunotherapy with dendritic cells can be personalized to target specific cancer neoantigens, making the treatment highly specific to each patient's unique cancer profile and avoiding significant collateral damage.
This is further supported by Ingels et al. (2024) [10], whose research in lung cancer patients showed that DCV induced long-lasting immune responses with minimal side effects – only grade 1-2 adverse events were observed, compared to the often severe side effects of traditional treatments.
Thus, the advantages of dendritic cell therapy over traditional methods are significant. While chemotherapy and radiation often cause severe side effects like fatigue, nausea, and immune system suppression, dendritic cell therapy typically produces minimal undesirable reactions. Dendritic cell vaccines for cancer immunotherapy Germany offers are particularly effective in cases where standard treatments show limitations, such as in non-immunogenic tumors, and can be carried out even in debilitated patients.
Comparison of the effectiveness of DCV and standard approaches
Based on clinical data from Booking Health.
| Treatment method | Duration | Response rate stage 4 | Survival rate |
|---|---|---|---|
| Dendritic cell therapy | One-time procedure | 60%-80% | ~80% for advanced cancer |
| Standard chemotherapy | Several cycles | Less than 10% | ~20% for advanced cancer |
| Standard immunotherapy: without individual production | Several cycles | 35-45% | 30-50% |
Dendritic Cells Cancer Treatment in Germany: For Which Tumors
After the start of active clinical use, DCT cancer treatment showed promising results. It is highly effective in patients with malignancies like melanoma and brain tumors such as glioblastoma. In combination with other treatments notable response was indicated in cases of solid tumors such as breast, pancreatic, lung, bowel, and prostate cancers. Osteosarcoma, soft tissue sarcoma, cervical cancer, and pleural mesothelioma are some other malignancy types where DC vaccination can be used to help prevent recurrence and progression. With constant research, the use of dendritic cells therapy for cancer in Germany is getting more recognition and helps patients from all around the world to get their disease under control.
DCV has demonstrated outstanding results in the treatment of the following cancers [7]:
- Treatment of melanoma with dendritic cells
- Treatment of brain tumors with dendritic cells
- Treatment of breast cancer with dendritic cells
- Treatment of bowel cancer with dendritic cells
- Treatment of osteosarcoma with dendritic cells
- Treatment of soft tissue sarcoma with dendritic cells
- Treatment of pancreatic cancer with dendritic cells
- Treatment of lung cancer with dendritic cells
- Treatment of prostate cancer with dendritic cells
- Treatment of cervical cancer with dendritic cells
Matching a patient to dendritic cell therapy in general is a different task from matching them to the right protocol, at the right center, with the physician who has the deepest documented experience in their specific tumor type.
Booking Health's medical team works through that distinction before making any recommendation — because the breadth of DCV's applicability is only clinically meaningful when the specific implementation is precise.
BOOK CONSULTATIONWhen Is Dendritic Cell Therapy Used in the Oncology Treatment Process?
Dendritic cell vaccination (DCV) use is not limited to a particular stage of cancer treatment. One of its many benefits is that it can be integrated into the treatment plan and be combined with other types of therapies, from modern to standard approaches. Also, it can be used for all patients, no matter what stage of tumor they are diagnosed with.
It can be applied after the cytoreductive surgery to target left-out cancer, as well as in later stages, paired with systemic chemotherapy or other immunotherapeutic approaches. The multimodal use enhances the treatment effectiveness and creates more favorable conditions for immune activation. One of the studies indicates that in patients with non-small cell lung cancer, adding DCV immunotherapy to chemotherapy significantly increased survival. The 2-year survival rate was 3 times higher, and the 3-year survival rate was 11 times higher compared to chemotherapy alone [11].
Can Other Cancer Therapies Work with Dendritic Cell Therapy?
One of the main combinations of DCV is using it with chemotherapy. This creates a favorable environment for antigen-presenting cells by eliminating the tumors’ immunosuppressive properties. Research shows that the use of DC and chemotherapy results in reduced toxicity and improved outcomes. Because cancer tissue often inhibits the effect of dendritic cell vaccination, standard therapies like chemo/radiotherapy help to enhance the activation of the immune system and hamper the immunosuppressive effects.
After DCV in advanced cancer, patients can expect relief of cancer symptoms and improved survival. The effect of vaccination remains for a long time, as the anti-cancer immunity stimulated by the first course of vaccination maintains independently without repeated procedures.
When receiving dendritic cell cancer in Germany treatment, you can have access to this treatment at every stage. Booking Health, with the multidisciplinary team of experts, will be able to integrate DCV before starting standard therapy, alongside chemotherapy or radiotherapy, and after completion of the main protocol as a maintenance and anti-recurrence strategy. In dendritic cell therapy cancer Germany experience, patients significantly benefit from this approach by achieving disease stabilization, tumor reduction, and in some cases complete cancer regression and long-term recovery.
Why Are More Cancer Patients Choosing Dendritic Cell Therapy?
Cancer is a scary diagnosis, but it’s important not to give up and continue looking for help. Patients who contact Booking Health can be sure that their best interests are kept throughout the whole process, and they receive treatment that gives them a chance to achieve control of their disease. Look at some of our patients’ stories:
Particularly compelling is the case of Daria Rogers, who sought treatment for glioblastoma multiforme (GBM), one of the most aggressive brain tumors. Three months after being treated at one of the dendritic cell cancer treatment clinics in Germany, her MRI results showed remarkable improvement. "Only dendritic cell treatment, for cancer, Germany provides, could be responsible for our results," she emphasizes, noting that the therapy complemented her overall treatment strategy effectively.
Another story is about Magdalena Ivanova from Bulgaria, who was battling stage IV breast cancer. She underwent numerous cycles of chemotherapy that wore out her body and mental health. "Anyone who goes through this therapeutic process knows how difficult it is", comments Magdalena. She contacted Booking Health for help and got the chance to receive the dendritic cancer vaccine Germany offers. And it provided the best results possible – full tumor control. "It was a fulfillment of my hopes, and I am happy with that," indicates Magdalena.
VIDEO
Magdalena Ivanova:
Real-Life Example of How
Dendritic Cell Vaccination Changes Lives
Dendritic Cell Therapy
FIND THE RIGHT SPECIALIST FOR MY CASE
These real-world cases highlight not just the medical efficacy of DC therapy, but also its practical advantages – the treatment process is straightforward, with minimal disruption to patients' lives. As Daria advises other cancer patients: "You need to go early, you need to go quickly." Such testimonials demonstrate why this modern immunotherapy is gaining recognition as a promising option for cancer treatment.
VIDEO
Daria Rogers, Ireland:
Positive Treatment Response
and Prolonged Disease Control
Following Dendritic Cell Therapy for Glioblastoma
Dendritic Cell Therapy
CHECK IF A BETTER SOLUTION EXISTS FOR YOU
What Daria's and Magdalena's outcomes share is not luck — it is the consequence of reaching the right center at a stage when the immune system still had the capacity to respond, which means timing is not incidental to the result but structurally part of it. Both patients contacted Booking Health before exhausting further cycles of standard treatment, which preserved the immunological conditions that DCV requires to generate a durable response.
For patients currently weighing their options, this is the practical implication of Daria's advice to "go early, go quickly": not urgency for its own sake, but the clinical reality that each additional cycle of immunosuppressive chemotherapy narrows the window in which a therapy that depends on immune activation can work at full strength.
BOOK CONSULTATIONPossible Side Effects and Contraindications of Dendritic Cell Therapy
Dendritic cell vaccination is usually considered a safe procedure because the vaccine is developed from the patient's own immune system. This lowers the response of the body because it considers the vaccine as its own and does not modulate the reaction towards it. As with any vaccination, it can have some side effects that include:
- Low fever
- Fatigue
- Swelling at the injection site
- Headache
- Short-term chills
Some of the limitations of DCV use are:
- Severe immunodeficiency with low immune cell count
- Organ failure during end-stage disease
- Hematologic malignancies, where the tumor directly suppresses dendritic cell function
- Severe autoimmune conditions
Standard treatment options vs dendritic cell therapy
Based on clinical data from Booking Health.
| Treatment option | Indications | Side effects | Disadvantages | Benefits |
|---|---|---|---|---|
| Dendritic cell therapy | all malignant tumors of all stages | minimal (flu-like symptoms) | individualized manufacturing is available at specialized centers only | highly personalized, life-long immunity after a single injection, minimal side effects |
| Standard immunotherapy: without individual production | specific malignant tumors of all stages | mild to moderate (rash, fatigue) | risk of severe immune-related adverse events, high proportion of non-responders, need for continuous long-term treatment | no need for patient-specific cell production, broader availability across treatment centers |
| Chemotherapy | malignant tumors of all stages | severe (nausea, hair loss) | systemic side effects, low quality of life during treatment, development of resistance over time, and high recurrence rate | widely available, effective for systemic disease, temporarily slows tumor growth |
Step-by-Step Process of Dendritic Cell Cancer Therapy
Dendritic cell therapy is one of the most efficient cancer treatment options. The main obstacle in oncology treatment is the lack of immunological tumor suppression. Malignancies manage to hide from the immune system, so they have enough time to develop into a tumor.
The DCV can be performed at any stage of cancer treatment and effectively complements all types of oncological care. For vaccine manufacturing, several approaches can be used. While tumor tissue samples can be utilized when available, they are not mandatory for treatment. Liquid biopsy, a sophisticated method that detects circulating tumor particles in the blood, provides an effective alternative for identifying cancer markers.
Let's imagine that you are about to receive treatment with a dendritic cell cancer vaccine Germany provides. The procedure can vary between health care centers and your specific circumstances, but usually it looks like this:
Day 1 (30min): You arrive at your first appointment. The medical team will take your full medical history and perform all the necessary examinations. You will discuss other possible therapeutic options, nutrition, and complementary medicines. At the end, you will make an informed consent to receive the vaccination.
Day 2 (90min): In the morning, at the center, 150-200ml of your blood will be taken with further administration of vitamin C and vitamin B-complex. Also, an intramuscular vitamin D injection (50.000 IU) is given to stimulate the immune system. An important note is that patients can have breakfast before blood collection.
Day 9 (90min): It is the day of vaccine administration. You can have breakfast before the treatment. The dendritic cells are injected intradermally with a later infusion containing vitamin C and vitamin B-complex. Furthermore, an intramuscular vitamin D injection (50,000 IU) is given. You will be recommended to supplement vitamin D with 40,000 IU per week orally.
Leading Clinics for Cancer Treatment with Dendritic Cell Therapy
Not many hospitals worldwide can perform dendritic cell vaccination because it’s a highly specialized and modern treatment. Due to the need for advanced laboratory equipment and GMP-compliant cell processing facilities, the therapy is the most developed in Germany, but can also be performed in selected centers in Switzerland, Japan, and the United States. Dendritic cells for cancer therapy Germany offers are available in several hospitals, making them one of the most experienced in the field for many years. Some of the facilities where you can receive dendritic cells cancer vaccine Germany provides are:
IOZK Immuno-Oncology Center in Cologne
It specializes in individualized immune-based concepts and focuses on a combination of dendritic cell vaccination with other treatments.
Praxisgemeinschaft für Zelltherapie in Duderstadt
It is considered a research facility for molecular therapies, including DCV. It provides personalized treatment strategies and works with advanced laboratory technologies.
The three centers listed above differ not only in their geographic location but in their clinical emphasis — which matters because a patient with glioblastoma and a patient with metastatic pancreatic cancer are not best served by the same protocol or the same physician, even within the same therapy category.
Laboratories Dr. Gansauge has the deepest published record in solid tumors across the widest range of histological types; IOZK's strength lies in its combination protocols integrating DCV with checkpoint inhibitors and virotherapy; Praxisgemeinschaft für Zelltherapie specializes in molecular precision approaches for cases requiring highly individualized antigen design.
Booking Health's role is not to list these options but to analyze a patient's specific diagnosis, prior treatment history, and immune profile against each center's documented outcomes — and then make a single, reasoned recommendation rather than leaving the patient to choose between names they have no clinical basis to evaluate.
Cost of Dendritic Cell Therapy Treatment
The cost of getting DC therapy significantly differs depending on the country. The price is indicated by laboratory standards, equipment availability, policy regulations, and more. Because DC requires complex and individualized production, only leading healthcare facilities can offer this type of modern therapy.
The dendritic cell-based cancer vaccine Germany offers is considered among the most advanced in the world, thanks to the country’s high level of scientific research and the presence of leading immunologists with many years of experience. This also allows for a shorter waiting list and well-established clinical protocols for DC therapy. The price of dendritic vaccine cancer Germany provides is also more affordable, ranging from €20,000 to €38,000, compared to the United States, where it ranges from €100,000 to €150,000, and the waiting time can take months. In Great Britain and Australia, dendritic cell therapy is generally not available.
Dendritic cell cancer treatment cost in different countries
* Costs are approximate and may vary depending on the hospital and individual patient requirements.
| Country | Dendritic cell therapy price |
|---|---|
| Germany* | €20,000 - €38,000 |
| USA | €100,000 - €150,000 |
| Great Britain | Not available |
| Australia | Not available |
Increasing the Effectiveness of Dendritic Cells in Cancer by Combining Them with Other Treatments
In order to increase effectiveness, dendritic cells cancer immunotherapy Germany offers is used in a complex treatment plan. It is important to get evaluated by the professional multidisciplinary team to create a specific combination of therapies that are personalized to your specific cancer type and situation. It is aimed to enhance the activation of antitumor immunity and improve overall clinical outcomes. To maximize the activation of antitumor immunity, oncologists in Europe combine vaccination with other advanced techniques:
- Virotherapy. Tumors are infected with an oncolytic virus, such as the Newcastle disease virus (NDV). The immune system recognizes the cells affected by the virus and actively destroys them.
- Hyperthermia. With local heating of the affected body region or general heating of the whole body, tumors produce substances that the immune system can find and destroy.
- Therapy with immune checkpoint inhibitors. Tumors can affect the human immune system, blocking the already existing anticancer response. Drugs from the group of immune checkpoint inhibitors restore anticancer immunity.
- Modulation of the tumor microenvironment. As the tumor grows, it forms a surrounding microenvironment with favorable conditions: active blood supply, nutrients, and growth factors. Oncologists who specialize in dendritic cell therapy for cancer Germany offers explore these factors and deprive the tumor of the conditions necessary for its active growth.
- Optimization of the level of trace elements and vitamins. Nutrients are required for the normal functioning of the immune system, e.g., vitamins A and E, zinc, and fiber. In patients with oncology, these substances are actively absorbed by the tumor. Oncologists adjust the patient's diet to make up for all deficiencies. Special nutritional formulas and dietary supplements are often prescribed.
- Regional chemotherapy (RC). RC first reduces tumor burden by delivering high concentrations of cytotoxic drugs directly to the tumor site. The combination with DCV improves local tumor control by targeting residual tumors systemically.
- Chemotherapy. Certain chemotherapeutic drugs can create a favorable environment for DC therapy.
Logistics can break a patient before treatment ever begins. Translating medical records, making appointments, thinking about visa requirements, language barriers – each task demands expertise that most families simply don't have. And they manage all of this while facing a serious illness.
This is where Booking Health steps in. With over 20 years in international oncology and ISO 9001 quality certification, they absorb the entire coordination burden – so patients don't have to. Documentation, translations, travel arrangements, hotel bookings, airport transfers, interpreter support: every detail handled. Every single one.
Get full treatment coordination supportDendritic Cell Therapy: Success Stories of Patients Through Booking Health
Dendritic Cell Cancer Treatment in Germany with Booking Health
Finding the best treatment strategy for your clinical situation is a challenging task. Being already exhausted from multiple treatment sessions, having consulted numerous specialists, and having tried various therapeutic interventions, you may be lost in all the information given by the doctors. In such a situation, it is easy to choose a first-hand option or to follow standardized therapeutic protocols with a long list of adverse effects instead of selecting highly specialized innovative treatment options.
To make an informed choice and get a personalized cancer management plan, which will be tailored to your specific clinical situation, consult medical experts at Booking Health. Being at the forefront of offering the latest medical innovations for already 12 years, Booking Health possesses solid expertise in creating complex cancer management programs in each case.
As a reputable company, Booking Health offers personalized cancer treatment plans with direct clinic booking and full support at every stage, from organizational processes to assistance during treatment. We provide:
- Assessment and analysis of medical reports
- Development of the medical care program
- Selection of a suitable treatment location
- Preparation of medical documents and forwarding to a suitable clinic
- Preparatory consultations with clinicians for the development of medical care programs
- Expert advice during the hospital stay
- Follow-up care after the patient returns to their native country after completing the medical care program
- Taking care of formalities as part of the preparation for the medical care program
- Coordination and organization of the patient's stay in a foreign country
- Assistance with visas and tickets
- A personal coordinator and interpreter with 24/7 support
- Transparent budgeting with no hidden costs
Health is an invaluable aspect of our lives. Delegating management of something so fragile yet precious should be done only to experts with proven experience and a reputation. Booking Health is a trustworthy partner who assists you on the way of pursuing stronger health and a better quality of life. Contact our medical consultant to learn more about the possibilities of personalized treatment with innovative methods for metastatic cancer with leading specialists in this field.
Booking Health holds ISO 9001 quality certification, reflecting well-established processes and strict quality control at every stage of the treatment journey — not just at the initial consultation, but throughout.
Frequently Asked Questions of Our Patients About Dendritic Cell Cancer Treatment
Dendritic cells vaccine for cancer Germany offers is an advanced form of immunotherapy that uses dendritic cells to stimulate the immune system to attack cancer cells. These cells are collected from the patient, modified to recognize cancer, and reintroduced into the body to enhance the immune response against the tumor. Long-lasting immunity can be achieved with the use of a dendritic cell vaccine. Cancer Germany treatment aimed to provide just that.
The effectiveness of dendritic cell therapy varies depending on the type and stage of cancer. Dendritic therapy for cancer Germany offers have shown promising results, with many patients experiencing significant improvements in their condition and prolonged survival rates.
Dendritic cells therapy cancer Germany offers is generally well-tolerated, with most side effects being mild and temporary. Common side effects include fever, fatigue, and injection site reactions. Severe side effects are rare but can occur, necessitating close monitoring by healthcare professionals. Many patients explore dendritic therapy cancer Germany options because of the high quality control in specialized oncology centers.
Dendritic cell vaccines cancer Germany provides can be used to treat various types of cancer, including melanoma, prostate cancer, lung cancer, breast cancer, and glioblastoma. It is particularly beneficial for cancers that have not responded well to conventional treatments. Patients looking for innovative treatment may explore dendritic cells cancer Germany programs.
Dendritic cell cancer treatment Germany offers involves collecting dendritic cells from the patient, modifying them in a laboratory to recognize cancer cells, and then injecting them back into the patient's body. This process helps the immune system identify and destroy cancer cells more effectively.
When receiving dendritic cells treatment cancer Germany provides, during an outpatient procedure, blood monocytes are collected and cultured with specific growth factors and tumor antigens to develop into mature dendritic cells. The personal dendritic cell vaccine Germany offers is later injected back to stimulate an immune response against cancer cells.
Dendritic cell cancer therapy Germany offers is generally available for adult patients over 18 years old, though specific age limits may vary by treatment center and clinical protocols.
The cost of cancer dendritic cell therapy Germany provides depends on the type of tumor, the stage of the disease, and the number of vaccination courses. On average, a full course costs between 20,000€ and 38,000€, which includes the laboratory production of the personalized vaccine, medical supervision, and follow-up.
Germany is a leading country for dendritic cells and cancer immunotherapy. Germany has specialized oncology centers that provide careful patient selection. They do personalized vaccine preparation and close monitoring during therapy. Dendritic cells cancer therapy Germany provides also combines established protocols with innovative immune-based approaches (to maximize safety and effectiveness).
Dendritic cells cancer vaccine Germany offers is considered a safe and effective treatment. The performed in Germany cancer vaccine causes minimal side effects compared to other standard approaches. If you seek a recognized destination for advanced immunotherapy, including dendritic cell, cancer Germany treatments offered at specialized oncology clinics.
Dendritic cell cancer treatment clinics have different prices depending on your specific case, but usually dendritic cell cancer vaccine costs around €20,000 – €38,000. This price for dendritic cells therapy for cancer Germany offers includes personalized vaccine preparation with the patient's own immune cells, short hospital stay, and follow-up appointments.
Stage 3 cancer treatment with dendritic cells Germany offers can be successfully used at this stage. DCT cancer treatment is administered during chemotherapy courses or on its own after the surgery to reduce the risk of relapse. Patients interested in innovative immunotherapy often travel for dendritic cell vaccine, cancer Germany treatment, where specialized clinics offer advanced personalized approaches.
Choose treatment abroad and you will be sure to get the best results!
Sources
01. Freddie Bray, Mathieu Laversanne, Hyuna Sung et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. [DOI] [PubMed]
02. Rebecca L. Siegel, Tyler B. Kratzer, Nikita Sandeep Wagle et al. Cancer statistics, 2026. A Cancer Journal for Clinicians, Volume 76, Issue 1 e70043. doi: 10.3322/caac.70043. [DOI]
03. Roman Volchenkov, Florian Sprater, Petra Vogelsang, Silke Appel. The 2011 Nobel Prize in physiology or medicine. Scand J Immunol. 2012 Jan;75(1):1-4. doi: 10.1111/j.1365-3083.2011.02663.x. [DOI] [PubMed]
04. Rachel L Sabado, Sreekumar Balan, Nina Bhardwaj. Dendritic cell-based immunotherapy. Cell Res. 2017 Jan;27(1):74-95. doi: 10.1038/cr.2016.157. Epub 2016 Dec 27. [DOI] [PubMed]
05. Min-Seon Song, Ji-Hee Nam, Kyung-Eun Noh, Dae-Seog Lim. Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration. J Immunol Res. 2024 Apr 8;2024:7827246. doi: 10.1155/2024/7827246. [DOI] [PMC free article]
06. Zhiyuan Xie, Yingjun Fang, Xinhao Zhang et al. The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy. Cell Death & Disease volume 16, Article number: 900 (2025). doi: 10.1038/s41419-025-08180-0. [DOI]
07. Jamal Motallebzadeh Khanmiri, Mohammad Khani-Eshratabadi, Fatemeh Seyedmoharram et al. Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges. Clin Exp Med. 2026 Feb 14;26(1):154. doi: 10.1007/s10238-026-02056-z. [DOI] [PMC free article]
08. Michal Kyr, Peter Mudry, Kristyna Polaskova et al. Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients. Int J Cancer. 2024; 155(8): 1443-1454. doi:10.1002/ijc.35062. [DOI]
09. Takashi Kamigaki, Rishu Takimoto, Sachiko Okada et al. Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens. Anticancer Res. 2024 Sep;44(9):3713-3724. doi: 10.21873/anticanres.17196. [DOI] [PubMed]
10. Joline Ingels, Laurenz De Cock, Dieter Stevens et al. Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum. Cell Rep Med. 2024 May 21;5(5):101516. doi: 10.1016/j.xcrm.2024.101516. [DOI] [PubMed]
11. Ran Chen, Xin Deng, Haochen Wu et al. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis. International Immunopharmacology. Volume 22, Issue 2, October 2014, Pages 451-464. doi: 10.1016/j.intimp.2014.07.019. [DOI]
Read:
01. Immunotherapy for Cancer Treatment
